Baby-CINO: CaffeINe Treatment Optimisation in Premature Infants

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This study investigates how brain activity and breathing changes in premature babies when their dose of caffeine treatment is changed or stopped. The study will assess premature babies receiving caffeine treatment as part of their clinical care. Brain activity will be recorded just before caffeine dose is changed and again two days afterwards. Breathing and other 'vital signs' (breathing rate, heart rate, oxygen saturation) will be recorded from the baby's monitor between the recordings of brain activity and for up to two weeks afterwards.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 8 months
Healthy Volunteers: f
View:

• Born to a mother aged 16 or over

• Admitted to the Newborn Care Unit, John Radcliffe Hospital

• Born prematurely (before 37 weeks' gestation)

• Parent given informed written consent

• Receiving caffeine citrate

Locations
Other Locations
United Kingdom
Newborn Care Unit, John Radcliffe Hospital
RECRUITING
Oxford
Contact Information
Primary
Caroline Hartley
caroline.hartley@paediatrics.ox.ac.uk
+44 1865 234537
Time Frame
Start Date: 2023-12-11
Estimated Completion Date: 2024-09-01
Participants
Target number of participants: 30
Treatments
Preterm infant
Preterm infants receiving caffeine (prescribed clinically) will be studied
Related Therapeutic Areas
Sponsors
Leads: University of Oxford

This content was sourced from clinicaltrials.gov